FDA — authorised 29 June 1998
- Application: NDA020864
- Marketing authorisation holder: ORGANON LLC
- Status: supplemented
FDA authorised Maxalt on 29 June 1998
Yes. FDA authorised it on 29 June 1998; FDA authorised it on 29 June 1998; FDA has authorised it.
ORGANON LLC holds the US marketing authorisation.